Company attributes
Location
B2X
CEO
Pitchbook URL
Legal Name
Adagio Therapeutics, Inc.
Legal classification
Number of Employees (Ranges)
11 – 50
Email Address
medinfo@adagiotx.com0
info@adagiotx.com0
Phone Number
+178181900800
+17812482771
Full Address
303 Wyman Street Suite 300 Waltham, MA 02451
1601 Trapelo Road Suite 178 Waltham, MA 024510
CIK Number
Place of Incorporation
Investors
IRS Number
274,590,529
Founded Date
2020
Total Funding Amount (USD)
595,899,816
Latest Funding Round Date
April 19, 2021
Business Model
Commerce
Stock Symbol
ADGI0
Exchange
Glassdoor ID
Former CEO
Latest Funding Type
Patents Assigned (Count)
2
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
336,000,000
SIC Code
2,8360
Ticker Symbol
ADGI
Adagio Therapeutics is a developer of antibodies intended to provide therapeutic and prophylactic treatments for the potentially emergent coronaviruses. The company engineer their treatments using antibody discovery and are designed to maximize potency and duration of effect.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
